Skip to content
Bamboo Works
Search
Register / Sign in
MSCI China
|
MSCI China Small-Cap
|
Hang Seng Index
|
Hang Seng China Enterprise
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • Eng
  • 简中
  • 繁中
Menu
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us

CRO

TaiMed is a digital operation platform for the life sciences industry, covering pharmaceutical R&D, pharmacovigilance, and pharmaceutical marketing.

FAST NEWS: TaiMed tumbles in Hong Kong trading debut

The Latest: Shares of Zhejiang Taimei Medical Technology Co. Ltd. (2576.HK) opened at HK$11.24 in their Tuesday trading debut, down 13.5% from their IPO price of HK$13, giving the medical…
October 8, 2024
2576.HK
During the Covid pandemic, lab monkeys that are one of Joinn’s main businesses were in short supply as companies rushed to develop Covid vaccines and drugs.

FAST NEWS: Joinn Lab swings to the red on falling revenue

The Latest: Joinn Laboratories (China) Co. Ltd. (6127.HK; 603127.SH), China’s leading non-clinical contract research organization (CRO), said on Wednesday it expects to report a net loss of 136 million yuan ($18.7…
July 11, 2024
6127.HK
603127.SHG
During the Covid pandemic, lab monkeys that are one of Joinn’s main businesses were in short supply as companies rushed to develop Covid vaccines and drugs.

FAST NEWS: Joinn Laboratories spents $3.7 million on share buyback

The Latest: Joinn Laboratories (China) Co. Ltd. (6127.HK; 603127.SH), China’s leading non-clinical contract research organization (CRO), said on Monday that since announcing a plan on Mar. 27 to repurchase its A…
June 4, 2024
6127.HK
603127.SHG
Joinn Laboratories, China’s leading non-clinical contract research organization (CRO), announced on Tuesday it expects to report a net profit of 311 million to 419 million yuan for 2023, down 61.1% to 71.1% from the previous year.

FAST NEWS: Joinn Lab profit plunges, sending shares to 52-week low

The latest: Joinn Laboratories (China) Co. Ltd. (6127.HK; 603127.SH), China’s leading non-clinical contract research organization (CRO), announced on Tuesday it expects to report a net profit of 311 million ($43.8…
January 24, 2024
6127.HK
603127.SHG
Contract drug services provider WuXi Biologics announced on Wednesday it has raised its guidance for new projects in 2024 from 80 to 110, despite a slowdown in biotech financing, after seeing a strong recovery in demand in the second half of last year.

FAST NEWS: WuXi Biologics boosts new projects target

The latest: Contract drug services provider WuXi Biologics (Cayman) Inc. (2269.HK) announced on Wednesday it has raised its guidance for new projects in 2024 from 80 to 110, despite a…
January 11, 2024
2269.HK

Joinn profits slide as lab monkey build-up backfires

The leading provider of pre-clinical drug research has predicted its first-half profits will plummet between 70% and 80% due to the falling value of its lab animals Key Takeaways: Joinn…
July 21, 2023
6127.HK
603127.SHG

Cash-strapped Viva Biotech sells stake and plans spinoff

The biotech has gained a capital injection from Temasek and a major Chinese investor, but the deal has not boosted investor confidence Key Takeaways: As well as tapping strategic investors,…
June 21, 2023
1873.HK
Load more

Recent Articles

TaiMed is a digital operation platform for the life sciences industry, covering pharmaceutical R&D, pharmacovigilance, and pharmaceutical marketing.
October 8, 2024

FAST NEWS: TaiMed tumbles in Hong Kong trading debut

2576.HK
July 11, 2024

FAST NEWS: Joinn Lab swings to the red on falling revenue

6127.HK
603127.SHG
June 4, 2024

FAST NEWS: Joinn Laboratories spents $3.7 million on share buyback

6127.HK
603127.SHG
January 24, 2024

FAST NEWS: Joinn Lab profit plunges, sending shares to 52-week low

6127.HK
603127.SHG
January 11, 2024

FAST NEWS: WuXi Biologics boosts new projects target

2269.HK
July 21, 2023

Joinn profits slide as lab monkey build-up backfires

6127.HK
603127.SHG
June 21, 2023

Cash-strapped Viva Biotech sells stake and plans spinoff

1873.HK

RELATED ARTICLES

  1. Airdoc Tech enjoys healing properties of medical AI rally
    February 27, 2025
    Airdoc Tech enjoys healing properties of medical AI rally
    2251.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

China stock insights and analysis for global investors: Bamboo Works unlocks investment opportunities in Chinese companies listed in the U.S. & Hong Kong.

  • About Us
  • Fast News
  • Audio/Video
  • Expert Corner
  • China ESG
Facebook Twitter Linkedin Weixin Weibo Youtube

Categories

  • New Energy
  • IPO
  • AI/Infrastructure/Resources
  • Education
  • Finance
  • Social Media/Entertainment
  • Consumer
  • Ecommerce
  • Healthcare/biotech
  • Property

Newsletter

Discover hidden China stock gems in our weekly newsletter
Copyright © 2021 - 2025 Bamboo Works. All rights reserved.